European Journal of Cancer Care最新文献

{"title":"Factors Associated With Upgrades From Biopsy Gleason Grades 1–3 to Radical Prostatectomy Gleason Grades 4–5 in Prostate Cancer Patients","authors":"Le Yu,&nbsp;Kewei Chen,&nbsp;Min Lu,&nbsp;Shaohui Deng,&nbsp;Ye Yan,&nbsp;Jianfei Ye,&nbsp;Fan Zhang,&nbsp;Shudong Zhang","doi":"10.1155/ecc/9940460","DOIUrl":"https://doi.org/10.1155/ecc/9940460","url":null,"abstract":"<div>\u0000 <p><b>Introduction:</b> Discordances of Gleason grade (GG) between biopsy and radical prostatectomy (RP) of prostate cancer (PCa) patients have raised great concerns. Our study aimed to identify these predictive factors for GG upgrading from biopsy to RP.</p>\u0000 <p><b>Methods:</b> We retrospectively reviewed the records of PCa patients receiving RP in our medical center. All patients underwent a standardized 12-core transrectal ultrasound (TRUS)–guided prostate needle biopsy, with site-specific submissions. Pretreatment PSA–related parameters were assessed 2 weeks before the operation. Prostate volume (PV) was calculated from images.</p>\u0000 <p><b>Results:</b> 679 patients were enrolled after screening. In the biopsy GG 1–3 group, 91 patients experienced upgrades. The multivariable analysis revealed that total PSA (tPSA) (<i>p</i> value &lt; 0.01) and perineural invasion (<i>p</i> value = 0.01) were significantly associated with the likelihood of upgrading compared to the concordant group.</p>\u0000 <p><b>Conclusion:</b> The GG 4 group demonstrated the lowest rate of concordance between biopsy and RP. Our analysis identified tPSA levels and perineural invasion as independent predictors of GG upgrading from biopsy GG 1–3 to RP GG 4–5 in PCa patients.</p>\u0000 </div>","PeriodicalId":11953,"journal":{"name":"European Journal of Cancer Care","volume":"2025 1","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/ecc/9940460","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143481482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"‘Death Doulas’ are not yet an Issue in German Palliative Care—A National Survey of Palliative Care Providers","authors":"Christian Volberg,&nbsp;Aboud Makdsi,&nbsp;Jannis Eersink,&nbsp;Juliana Kushner,&nbsp;Astrid Morin,&nbsp;Martin Gschnell","doi":"10.1155/ecc/6654399","DOIUrl":"https://doi.org/10.1155/ecc/6654399","url":null,"abstract":"<div>\u0000 <p><b>Background:</b> The support of ‘Death Doulas’ (DD) in the last phase of life is becoming more and more present in the individual care of the dying. This trend is slowly being brought to Germany from other countries. However, the extent to which this possibility of end-of-life care is offered in Germany or requested by patients is still unclear.</p>\u0000 <p><b>Aim:</b> With this nationwide survey, we want to show to what extent DD support palliative care in Germany and whether a need for this activity is seen.</p>\u0000 <p><b>Design:</b> Germany-wide cross-sectional study among palliative care institutions.</p>\u0000 <p><b>Setting/Respondents:</b> All German hospices, palliative care units and specialized outpatient palliative care services were contacted by post and asked to participate in this anonymous survey.</p>\u0000 <p><b>Results:</b> In total, we received 338 (36.4%) responses. A total of 27% of the respondents state that they are familiar with the term DD but only 18 institutions (5.3%) use the support. Patients’ satisfaction is recognized as overall satisfied. A total of 95% of the institutions who work with DD would recommend other palliative care institutions to work with DD as well. More information about this topic is wished by 61%.</p>\u0000 <p><b>Conclusion:</b> DD is not yet an issue in German palliative care. There seems to be little need as the support of the dying is carried out by other professional groups and volunteers. Since DD have another approach in their work, it would be interesting to see if a broader knowledge about their work and offer could improve quality in the dying process.</p>\u0000 </div>","PeriodicalId":11953,"journal":{"name":"European Journal of Cancer Care","volume":"2025 1","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/ecc/6654399","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143466286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"What is “Coaching” in Interventions for Patients in Cancer Care Research? A Systematic Scoping Review","authors":"P. Gérain,&nbsp;R. Tanious,&nbsp;W. Jacquet,&nbsp;A. Meziani,&nbsp;E. Van Hoof","doi":"10.1155/ecc/2858931","DOIUrl":"https://doi.org/10.1155/ecc/2858931","url":null,"abstract":"<div>\u0000 <p><b>Objective:</b> Cancer has an impact on psychosocial well-being as well as on mental health. Coaching increasingly appears as a source of psychosocial support to cancer patients. However, we currently lack a clear framework for coaching in that context. The present review aims to better define the concept of coaching in interventions for patients in cancer care research, as well as to synthesize frameworks, techniques, and providers.</p>\u0000 <p><b>Methods:</b> A conceptual scoping review based on PRISMA was performed on studies focusing on coaching and cancer published in peer-reviewed journals until November 2024. Studies on coaching and cancer were systematically extracted from five online databases and then screened.</p>\u0000 <p><b>Results:</b> A total of 237 studies were included after screening. Less than 15% of the studies provided an explicit definition of coaching. Six coaching categories were identified based on their goal, in addition to a general form of coaching. Coaching in cancer care occurs during the acute treatment phase as well as during the posttreatment phase. Most providers were healthcare professionals, despite an important heterogeneity. Techniques were sorted into 9 sets of techniques implemented in coaching interventions, including goal setting, providing support, and self-regulation.</p>\u0000 <p><b>Conclusions:</b> This review provided structure to the field of coaching in cancer. It also showed that defining a field only on the word “coaching” does not appear sufficient to reflect the current heterogeneity. Consequently, there is a necessity for the field to clarify its theoretical frameworks, targets, and intervention components to increase the necessary reproducibility and cumulative knowledge.</p>\u0000 </div>","PeriodicalId":11953,"journal":{"name":"European Journal of Cancer Care","volume":"2025 1","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/ecc/2858931","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143447039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Variation in the Diagnostic and Treatment Pathway in Peritoneal Mesothelioma: A Mixed-Methods Study in the United Kingdom","authors":"Samantha Westbrook,&nbsp;Stephanie Ejegi-Memeh,&nbsp;Virginia Sherborne,&nbsp;Clare Warnock,&nbsp;Emily Wood,&nbsp;Sophia Stanford,&nbsp;Rayan Taher,&nbsp;Lorraine Creech,&nbsp;Lynne Squibb,&nbsp;Caroline Twist,&nbsp;Clare Gardiner","doi":"10.1155/ecc/8875835","DOIUrl":"https://doi.org/10.1155/ecc/8875835","url":null,"abstract":"<div>\u0000 <p>Peritoneal mesothelioma (PM) is a rare and aggressive cancer with a significant impact on the patient quality of life. This study aimed to explore variability in the care pathway of people with PM and to explore the patient experience of the care pathway. A mixed-methods, longitudinal approach was employed. The three stages of the study were (1) cross-sectional survey of PM patients and family members exploring demographic characteristics, patient pathway, experiences of treatment and care; (2) qualitative, case study series of individual patients, their family member/carer/friend and professionals; and (3) case note review of case study patients living with PM. Forty-seven patients (30 women and 17 men) responded to the survey. We recruited seven case studies comprising seven patient participants, eight carers and six professionals. Findings revealed a significant delay in diagnosis due to nonspecific symptoms and challenges in differential diagnosis. The study highlights the need for improved timely diagnosis, enhanced communication between healthcare providers and patients, and referral to specialist mesothelioma multidisciplinary teams. Recommendations include the need to implement smoother treatment and management pathways, to increase referrals to specialist multi-disciplinary teams and to engage patients in decision-making throughout the treatment pathway.</p>\u0000 </div>","PeriodicalId":11953,"journal":{"name":"European Journal of Cancer Care","volume":"2025 1","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/ecc/8875835","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143431197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Risk Factors of Venous Thromboembolism After Radical Hysterectomy in Patients With Cervical Cancer","authors":"Bei Feng,&nbsp;Zehua Wang,&nbsp;Liqiong Cai,&nbsp;Xiaoqi He,&nbsp;Yuan Zhang,&nbsp;Jing Cai","doi":"10.1155/ecc/9573736","DOIUrl":"https://doi.org/10.1155/ecc/9573736","url":null,"abstract":"<div>\u0000 <p>This retrospective study aimed to determine the risk factors for venous thromboembolism (VTE) in patients undergoing radical hysterectomy for cervical cancer. Data from 366 patients who underwent radical surgery between June 2020 and December 2021 were collected from medical records. The patients were divided into a thrombosis group and a nonthrombotic group based on the presence or absence of VTE. Multivariate analyses revealed that age greater than 45 years, open radical hysterectomy surgery, an operation time exceeding 4 hours, intraoperative blood transfusion, and postoperative plasma D-dimer levels greater than 2.0 mg/L were significant independent risk factors for postoperative VTE, which could be used to help identify patients at an increased risk of VTE.</p>\u0000 </div>","PeriodicalId":11953,"journal":{"name":"European Journal of Cancer Care","volume":"2025 1","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/ecc/9573736","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143431196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Navigating What Is Not Known—Patients’ Experience of the Life Threat Connected to Allogeneic Stem Cell Transplantation","authors":"Alinda Reimer,&nbsp;Carolin Schepers,&nbsp;Merle Ley,&nbsp;Berenike Schoerger,&nbsp;Anne Pralong,&nbsp;Raymond Voltz,&nbsp;Udo Holtick,&nbsp;Marco Herling,&nbsp;Steffen T. Simon","doi":"10.1155/ecc/8743444","DOIUrl":"https://doi.org/10.1155/ecc/8743444","url":null,"abstract":"<div>\u0000 <p><b>Background:</b> Allogeneic stem cell transplantation (allo-SCT) represents a firmly established therapeutic option for patients facing (non-)malignant haematological diseases. Despite its curative potential, however, this treatment is associated with substantial morbidity and mortality rates as well as a decreased quality of life. Given this context, a scientific void needs to be addressed: How do patients deal with the existential situation of being exposed to a life threat despite the curative potential of their treatment? This study aims to explore the patients’ experiences considering their life threat in the context of the allo-SCT.</p>\u0000 <p><b>Methods:</b> Qualitative semistructured, in-depth interviews were conducted with patients treated by allo-SCT over the course of transplantation (before, during or after hospitalization). Interview data were interpreted using category-based qualitative content analysis.</p>\u0000 <p><b>Results:</b> Seventeen interviews were conducted. Results revealed a strong focus on hope and avoidance of dealing with the life threat. At the same time, challenges due to the lack of alternative treatments and the uncertain course were highlighted. The data revealed that patients wished to receive support by healthcare professionals, their carers and their social environment in general. Beyond that, patients desired to obtain honest information within an open discussion about a realistic prognosis and risk of treatment and course of disease.</p>\u0000 <p><b>Conclusion:</b> The findings emphasize an interplay between hope, avoidance and psychological distress in the face of the patients’ life threat. To assist allo-SCT recipients in navigating their life threat during treatment, it is desirable to establish avenues that provide adequate support.</p>\u0000 <p><b>Trial Registration:</b> German Registry of Clinical Trials: DRKS00027290</p>\u0000 </div>","PeriodicalId":11953,"journal":{"name":"European Journal of Cancer Care","volume":"2025 1","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/ecc/8743444","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143389014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Elevated CA15-3 Levels in Myeloid Disorders: Clinicopathological Correlation","authors":"Samah Saharti,&nbsp;Mohamad Qari","doi":"10.1155/2025/5824491","DOIUrl":"https://doi.org/10.1155/2025/5824491","url":null,"abstract":"<div>\u0000 <p><b>Background:</b> Serum tumor markers are beneficial to patients with advanced cancer because they help in early diagnosis, determining prognosis, predicting response to certain medications, and monitoring therapy. The prognostic value of cancer antigen 15-3 (CA15-3) serum-level changes in breast cancer is very well established. The main cause behind the elevation of CA 15-3 is metastatic breast carcinoma. In this study, we will run a record review to study comprehensively the clinical association between chronic myeloid disorders and CA15-3 elevation.</p>\u0000 <p><b>Method:</b> In this retrospective study, we run CA15-3 on 106 patients with different myeloid disorders diagnosed between 2008 and 2021 from several tertiary care centers in Saudi Arabia, Jeddah, majority of which (38 cases) were diagnosed with chronic myeloid leukemia (35.8%). Others had essential thrombocytosis (22.6%), chronic myeloproliferative neoplasm (20.8%), myelofibrosis (7.5%), acute myeloid leukemia (4.7%), myelodysplastic syndrome (4.7%), and polycythemia vera (3.8%).</p>\u0000 <p><b>Result:</b> An increase in CA15-3 was seen in 50% of all cases. In particular, polycythemia vera showed an elevation in 100% of the cases (4 out of 4). Second in expressivity is myelodysplastic syndrome (80%, 4 out of 5 cases). Close in value is myelofibrosis (75%, 6 out of 8 cases). The least association is noted between CA15-3 and essential thrombocytosis (16.7%, 4 out of 24 cases).</p>\u0000 <p><b>Conclusion:</b> When CA15-3 levels are considered during the time of myeloid disorder diagnosis, it shows an independent predictive value. More research is needed to determine the utility of these serum biomarkers in myeloid disorders decision-making. This is a thorough case series of chronic myeloid disorders inclusive of all myeloproliferative neoplasms besides myelodysplastic syndrome describing the association with CA15-3.</p>\u0000 </div>","PeriodicalId":11953,"journal":{"name":"European Journal of Cancer Care","volume":"2025 1","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2025/5824491","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143110805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Adopting a Dyadic Approach to Treating Chronic Cancer-Related Fatigue: A Mixed Methods Study to Assess Patients’ and Partners’ Needs, Benefits, Barriers and Preferences","authors":"Sophie I. van Dongen,&nbsp;Fabiola Müller,&nbsp;Rosalie A. M. van Woezik,&nbsp;Mariët Hagedoorn,&nbsp;Marije L. van der Lee","doi":"10.1155/ecc/8313220","DOIUrl":"https://doi.org/10.1155/ecc/8313220","url":null,"abstract":"<div>\u0000 <p><b>Introduction:</b> Chronic cancer-related fatigue (CCRF) is a common symptom among patients. Current therapies target the patient alone, while evidence suggests that targeting the dyad might be more beneficial.</p>\u0000 <p><b>Method:</b> Using a mixed methods design, we conducted two studies that together aimed to provide more insight into the needs, benefits, barriers and preferences regarding a couples therapy for CCRF. In a qualitative study, we conducted focus groups and semi-structured interviews with a purposive sample of 10 patients and 10 partners with experience of CCRF care, followed by thematic analysis. In a subsequent quantitative study, a convenience sample of patients (<i>n</i> = 172) and partners (<i>n</i> = 55) completed an online survey developed based on the qualitative findings.</p>\u0000 <p><b>Results:</b> In the qualitative study, both patients and partners expressed that a couples therapy could help them. Perceived benefits included empowerment of partners to support patients and improved couples communication. In the online survey, the need for a dyadic approach to CCRF therapy was confirmed by both patients (39%) and partners (91%). The benefits reported by most patients and partners were that partners could get attention for their own problems related to the patients’ cancer and fatigue (patients: 72%, partners: 86%) and receive advice on coping with fatigue (66% and 90%, respectively). Participants in both studies identified barriers, such as a fear of burdening partners with a couples therapy (50%). Partner involvement was considered desirable for most therapy elements (e.g., psychoeducation, contact with the therapist, exercises and relapse prevention). Yet, individual preferences varied widely.</p>\u0000 <p><b>Conclusion:</b> Results of both studies support the potential acceptability of a couples therapy for CCRF among patients and partners. Based on divergent preferences, we determined that a couples therapy must provide flexibility regarding the degree, intensity and type of partner involvement. Dyadic psychoeducation can be used as a solid starting point to manage expectations and get relief from perceived barriers.</p>\u0000 </div>","PeriodicalId":11953,"journal":{"name":"European Journal of Cancer Care","volume":"2025 1","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/ecc/8313220","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143115422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Awareness and Knowledge of Chemotherapy Among Cancer Patients at Suresh Wagle Memorial Cancer Centre, Kathmandu","authors":"Sabina Tamang,&nbsp;Urmila Prajapati,&nbsp;Gayatri Maharjan","doi":"10.1155/ecc/6384002","DOIUrl":"https://doi.org/10.1155/ecc/6384002","url":null,"abstract":"<div>\u0000 <p>Chemotherapy plays a crucial role in cancer treatment, targeting rapidly dividing abnormal and normal cells, which often leads to significant side effects. This study aimed to assess the awareness of chemotherapy among cancer patients at Suresh Wagle Memorial Cancer Centre, Tribhuvan University Teaching Hospital (TUTH), Kathmandu, Nepal. A descriptive cross-sectional design was employed, involving 103 cancer patients selected through nonprobability, purposive sampling. Data were collected via in-person interviews using a semistructured questionnaire. Statistical analysis, including chi-square tests, was conducted to explore associations between patients’ knowledge of chemotherapy and biodemographic variables. The results indicated that nearly half of the respondents, 50 (48.5%), had moderate knowledge of chemotherapy, while a significant association was found between the cycle of chemotherapy and access to health information, with a <i>p</i> value of less than 0.05. The study highlights the need for regular patient education and counseling to enhance awareness and understanding of chemotherapy. The use of educational materials such as brochures, videos, and online resources is recommended to reinforce patients’ knowledge and improve their overall quality of life during treatment.</p>\u0000 </div>","PeriodicalId":11953,"journal":{"name":"European Journal of Cancer Care","volume":"2025 1","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/ecc/6384002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143115077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Improving Sexual Well-Being Support for Men With Prostate Cancer: The Health Professional Perspective","authors":"Megan Charlick,&nbsp;Kerry Ettridge,&nbsp;Tenaw Tiruye,&nbsp;Michael O’Callaghan,&nbsp;Sally Sara,&nbsp;Alexander Jay,&nbsp;Kerri Beckmann","doi":"10.1155/ecc/2875201","DOIUrl":"https://doi.org/10.1155/ecc/2875201","url":null,"abstract":"<div>\u0000 <p><b>Purpose:</b> The provision of evidenced-based sexual well-being support is considered a key metric of quality prostate cancer care. However, patients continually report high rates of unmet sexual health needs. To provide insight into the challenges healthcare professionals (HCPs) face in delivering sexual well-being support, we conducted a qualitative study.</p>\u0000 <p><b>Methods:</b> HCPs were recruited via professional organisations/networks and snowballing. Interviews were semistructured, conducted via telephone/video and transcribed verbatim. Interviews explored work experience, sexual support provided, challenges faced and areas of prioritisation to improve care delivery. Data were analysed using reflexive thematic analysis. The lack of representation from urologists and radiation oncologists was a limitation.</p>\u0000 <p><b>Results:</b> Twenty-one HCPs were interviewed, including nurses, pharmacists, sexologists, a physiotherapist and an oncologist. Eight key themes were identified. Themes 1–5 describe the challenges faced by HCPs in providing sexual well-being support, such as logistical issues and reliance on other HCPs. The remaining three themes describe areas of change recommended by HCPs to improve delivery of support, including standardisation of penile rehabilitation guidelines, training for specialists and GPs and prioritisation of multidisciplinary sexual well-being support as part of routine care.</p>\u0000 <p><b>Conclusions:</b> HCPs face several challenges in providing sexual well-being support to prostate cancer patients, which could be ameliorated through greater awareness and education about the importance of sexual well-being support and through standardising pathways and guidelines. Addressing challenges faced by HCPs in the delivery of sexual well-being support may ultimately improve patient experiences and reduce unmet sexual health needs following prostate cancer treatment.</p>\u0000 </div>","PeriodicalId":11953,"journal":{"name":"European Journal of Cancer Care","volume":"2025 1","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/ecc/2875201","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143114141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}